Three-dimensional human alveolar stem cell culture models reveal infection response to SARS-CoV-2

Youk, Jeonghwan, Kim, Taewoo, Evans, Kelly V., Jeong, Young-Il, Hur, Yongsuk, Hong, Seon Pyo, Kim, Je Hyoung, Yi, Kijong +13 more·2020·Cell Stem Cell

Cited by (266)

Items 101–200 of 266

  1. Hydroxypropyl Cyclodextrin Improves Amiodarone-induced Aberrant Lipid Homeostasis of Alveolar Cells
    Shuhei Kanagaki, Takahiro Suezawa, Keita Moriguchi, Kazuhisa Nakao, Masayasu Toyomoto, Yuki Yamamoto, Koji Murakami, Masatoshi Hagiwara, Shimpei Gotoh · 2021 · American Journal of Respiratory Cell and Molecular Biology
  2. Human pluripotent stem cell-based organoids and cell platforms for modelling SARS-CoV-2 infection and drug discovery
    Alice Maria Giani, Shuibing Chen · 2021 · Stem Cell Research
  3. Stem Cell–Derived Respiratory Epithelial Cell Cultures as Human Disease Models
    Jessica C. Orr, Robert E. Hynds · 2021 · American Journal of Respiratory Cell and Molecular Biology
  4. Perspectives of future lung toxicology studies using human pluripotent stem cells
    Atsushi Masui, Toyohiro Hirai, Shimpei Gotoh · 2022 · Archives of Toxicology
  5. SARS-CoV-2 infection studies in lung organoids identify TSPAN8 as novel mediator
    Lisiena Hysenaj, Samantha Little, Kayla R. Kulhanek, Oghenekevwe M. Gbenedio, Lauren Rodriguez, Alan S. Shen, Jean‐Christophe Lone, Leonard C. Lupin-Jimenez, Luke R. Bonser, Nina Kathrin Serwas et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  6. The mini lungs and other organoids helping to beat COVID
    Smriti Mallapaty · 2021 · Nature
  7. Polyvinyl alcohol scaffolds and supplementation support 3D and sphere culturing of human cancer cell lines by reducing apoptosis and promoting cellular proliferation
    Yukari Okita, Ling Zheng, Kunio Kawanishi, Hirotoshi Miyoshi, Kazuyoshi Yanagihara, Mitsuyasu Kato · 2021 · Genes to Cells
  8. Potential Impact of Diabetes and Obesity on Alveolar Type 2 (AT2)-Lipofibroblast (LIF) Interactions After COVID-19 Infection
    Marjan Nouri-Keshtkar, Sara Taghizadeh, Aisan Farhadi, Aysan Ezaddoustdar, Samira Vesali, Roya Hosseini, Mehdi Totonchi, Azam Kouhkan, Chengshui Chen, Jin‐San Zhang et al. · 2021 · Frontiers in Cell and Developmental Biology
  9. Airway and Alveoli Organoids as Valuable Research Tools in COVID-19
    Miriane de Oliveira, Maria Teresa De Síbio, Felipe Allan da Silva da Costa, Marna Eliana Sakalem · 2021 · ACS Biomaterials Science & Engineering
  10. 3D engineered tissue models for studying human-specific infectious viral diseases
    Kyeong Seob Hwang, Eun U Seo, Nakwon Choi, Jongbaeg Kim, Hong Nam Kim · 2022 · Bioactive Materials
  11. SARS-CoV-2 infection of airway organoids reveals conserved use of Tetraspanin-8 by Ancestral, Delta, and Omicron variants
    Lisiena Hysenaj, Samantha Little, Kayla R. Kulhanek, M. Magnen, Kriti Bahl, Oghenekevwe M. Gbenedio, M. Prinz, L. Rodriguez, Christopher R. Andersen, A. Rao et al. · 2023 · Stem Cell Reports
  12. Open questions in human lung organoid research
    Tessa Hughes, Krijn Kristian Dijkstra, Emma L. Rawlins, Robert E. Hynds · 2023 · Frontiers in Pharmacology
  13. Low level of tonic interferon signalling is associated with enhanced susceptibility to SARS-CoV-2 variants of concern in human lung organoids
    Meaghan Flagg, Kerry Goldin, Lizzette Pérez-Pérez, Manmeet Singh, Brandi N. Williamson, Nathanael D. Pruett, Chuong D. Hoang, Emmie de Wit · 2023 · Emerging Microbes & Infections
  14. Characterization of the SARS-CoV-2 Host Response in Primary Human Airway Epithelial Cells from Aged Individuals
    Subramaniyan Bharathiraja, Jason L. Larabee, Manish Bodas, Andrew R. Moore, Anthony W. G. Burgett, Dean A. Myers, Constantin Georgescu, Jonathan D. Wren, James F. Papin, Matthew S. Walters · 2021 · Viruses
  15. Diabetes and SARS-CoV-2–Is There a Mutual Connection?
    Anna P. Jedrzejak, Edyta Urbaniak, Jadwiga Waśko, Natalia Ziojla, Malgorzata Borowiak · 2022 · Frontiers in Cell and Developmental Biology
  16. Parallel use of human stem cell lung and heart models provide insights for SARS-CoV-2 treatment
    Rajeev Rudraraju, Matthew J. Gartner, Jessica Anne Neil, Elizabeth S. Stout, Joseph Chen, Elise J. Needham, Michael See, Charley Mackenzie-Kludas, Leo Lee, Mingyang Wang et al. · 2023 · Stem Cell Reports
  17. Experimental Models for SARS-CoV-2 Infection
    Taewoo Kim, Jeong Seok Lee, Young Seok Ju · 2021 · Molecules and Cells
  18. Organoids: physiologically relevant ex vivo models for viral disease research
    Yijing Wang, Dingkun Peng, Meilin Li, Yao Meng, Tianlong Li, Su Li, Hua‐Ji Qiu, Lian‐Feng Li · 2025 · Journal of Virology
  19. A novel alveoli-on-chip platform for modeling cyclic stretch in patient-derived alveolar epithelial cells cultured from organoids
    Mohammad Amin Hajari, Jan Schulte, Dario Príncipi, Damian Schnidrig, Sabine Schneider, Tobias Weber, Joo‐Hyeon Lee, Patrick Dorn, Pauline Zamprogno, Thomas M. Marti et al. · 2025 · Lab on a Chip
  20. Organoids in respiratory virus research: advances and perspectives
    Xingling Li, Haiqing Xiao, Ming Zhou, Chuanlai Yang, Xinyi Yang, Tong Cheng, Lunzhi Yuan, Ningshao Xia · 2025 · Molecular Biomedicine
  21. Human Pluripotent Stem Cell-Derived Alveolar Organoids: Cellular Heterogeneity and Maturity
    Ji‐Hye Jung, Se‐Ran Yang, Woo Jin Kim, Chin Kook Rhee, Seok‐Ho Hong · 2023 · Tuberculosis & respiratory diseases
  22. Advancing zoonotic respiratory virus research through the use of organoids
    Meaghan Flagg, Emmie de Wit · 2024 · Current Opinion in Virology
  23. Harnessing the power of microphysiological systems for COVID-19 research
    Nicole Kleinstreuer, Anthony M Holmes · 2021 · Drug Discovery Today
  24. Human organoid systems reveal in vitro correlates of fitness for SARS-CoV-2 B.1.1.7
    Mart Matthias Lamers, Tim I. Breugem, Anna Z. Mykytyn, Yiquan Wang, Nathalie Gröen, Kèvin Knoops, Debby Schipper, Jelte van der Vaart, Charlotte D. Koopman, Jingshu Zhang et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  25. Building a human lung from pluripotent stem cells to model respiratory viral infections
    Declan L. Turner, Sahel Amoozadeh, Hannah Baric, Edouard G. Stanley, Rhiannon B. Werder · 2024 · Respiratory Research
  26. Comparison of Contemporary and Historic Highly Pathogenic Avian Influenza A(H5N1) Virus Replication in Human Lung Organoids
    Meaghan Flagg, Brandi N. Williamson, Johan A. Ortiz-Morales, Tessa R. Lutterman, Emmie de Wit · 2025 · Emerging infectious diseases
  27. Exploiting the potential of lung stem cells to develop pro-regenerative therapies
    Robert E. Hynds · 2022 · Biology Open
  28. A comparative study of COVID-19 transcriptional signatures between clinical samples and preclinical cell models in the search for disease master regulators and drug repositioning candidates
    Henrique Chapola, Marco Antônio De Bastiani, Marcelo Mendes Duarte, Matheus Becker Freitas, Jussara Severo Schuster, Daiani Machado de Vargas, Fábio Klamt · 2023 · Virus Research
  29. Rapid endothelial infection, endothelialitis and vascular damage characterise SARS-CoV-2 infection in a human lung-on-chip model
    Vivek V. Thacker, Kunal Sharma, Neeraj Dhar, Gian-Filippo Mancini, Jessica Sordet‐Dessimoz, John D. McKinney · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  30. Activated interstitial macrophages are a predominant target of viral takeover and focus of inflammation in COVID-19 initiation in human lung
    T. Wu, K. Travaglini, Arjun Rustagi, Duo Xu, Yue Zhang, Leonid Andronov, SoRi Jang, A. Gillich, Roozbeh Dehghannasiri, Giovanny J. Martínez-Colón et al. · 2023 · bioRxiv
  31. Recent Advances of COVID-19 Modeling Based on Regenerative Medicine
    Bagher A. Larijani, Najmeh Foroughi Heravani, Mina Abedi, Akram Tayanloo-Beik, Mostafa Rezaei–Tavirani, Hossein Adibi, Babak Arjmand · 2021 · Frontiers in Cell and Developmental Biology
  32. Recent advances and applications of human lung alveolar organoids
    Sun Kyung Kim, Eunho Sung, Kyungtae Lim · 2024 · Molecules and Cells
  33. Alveolar epithelial stem cells in homeostasis and repair
    Andrea Tóth, Barbara Zhao, William J. Zacharias · 2021 · European Respiratory Society eBooks
  34. Halting SARS‐CoV‐2: lung organoids step up to the plate
    Sandra Lawrynowicz Leibel, Xin Sun · 2021 · The EMBO Journal
  35. Organotypic human ex vivo models for coronavirus disease 2019 research and drug development
    Sonia C. Youhanna, Shane C. Wright, Volker Martin Lauschke · 2021 · Current Opinion in Pharmacology
  36. Preparation and application of taste bud organoids in biomedicine towards chemical sensation mechanisms
    Shuge Liu, Ping Zhu, Yulan Tian, Yating Chen, Yage Liu, Wei Chen, Liping Du, Chunsheng Wu · 2022 · Biotechnology and Bioengineering
  37. Development trends of human organoid‐based COVID ‐19 research based on bibliometric analysis
    Minghui Li, Yuhong Yuan, Ting Zou, Zongkun Hou, Liang Jin, Bochu Wang · 2023 · Cell Proliferation
  38. Induction of alveolar and bronchiolar phenotypes in human lung organoids
    Laurence Hoareau, Agnete S. T. Engelsen, Marianne Aanerud, Maria Ramnefjell, Pirjo‐Riitta Salminen, Fabian Gärtner, Thomas Halvorsen, Helge Ræder, Mariann H. L. Bentsen · 2021 · Physiological Reports
  39. A novel human fetal lung-derived alveolar organoid model reveals mechanisms of surfactant protein C maturation relevant to interstitial lung disease
    Kyungtae Lim, Eimear N. Rutherford, Dawei Sun, Dick J. H. van den Boomen, James R. Edgar, Jae Hak Bang, Lydia E. Matesic, Joo‐Hyeon Lee, Paul J. Lehner, Stefan John Marciniak et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  40. Cyclohexylalanine-Containing α-Helical Amphipathic Peptide Targets Cardiolipin, Rescuing Mitochondrial Dysfunction in Kidney Injury
    Gwangsu Shin, Soonsil Hyun, Dong‐Woo Kim, Yoonhwa Choi, Kyu Hong Kim, Dong‐Min Kim, Soie Kwon, Dong Ki Kim, Seung Hee Yang, Jaehoon Yu · 2023 · Journal of Medicinal Chemistry
  41. The Local Anaesthetic Procaine Prodrugs ProcCluster® and Procaine Hydrochloride Impair SARS-CoV-2 Replication and Egress In Vitro
    Clio Häring, Johannes Jungwirth, Josefine Schroeder, Bettina Löffler, Beatrice Engert, Christina Ehrhardt · 2023 · International Journal of Molecular Sciences
  42. Stem cells part of the innate and adaptive immune systems as a therapeutic for Covid-19
    Greg Maguire · 2021 · Communicative & Integrative Biology
  43. Lung organoids as a human system for Mycobacteria infection modeling and drug testing
    Stephen Adonai Leon‐Icaza, Romain Vergé, Raoul Mazars, Laurence Berry, Céline Cougoule · 2025 · FEBS Journal
  44. Interferon-γ selectively promotes survival of alveolar progenitor cells in a human lung organoid model
    Antonella F. M. Dost, Katarína Balážová, Carla Pou Casellas, Lisanne Van Rooijen, Wisse Epskamp, Gijs J. F. van Son, Willine J. van de Wetering, Carmen López‐Iglesias, Harry Begthel, Peter J. Peters et al. · 2026 · The EMBO Journal
  45. Organoids as platforms for infectious disease research
    Kuan Liu, Yilan Zhao, Erika M. Joloya, Benedetta Artegiani, Sina Bartfeld, Young Ki Choi, Yuling Han, Delilah F. G. Hendriks, Martin Johannes Hoogduijn, James E. Hudson et al. · 2026 · Nature Reviews Bioengineering
  46. Using nanomaterials to address SARS-CoV-2 variants through development of vaccines and therapeutics
    Maria V. Hangad, Sarah Keshvani, Niya Kelpin, Jonathan Walters-Shumka, McKayla Hood, C. Volk, D. Pal, S. Willerth · 2022 · Frontiers in Materials
  47. Meta-analysis of Transcriptomic Data from Lung Autopsy and Cellular Models of SARS-CoV-2 Infection
    Nathan Araujo Cadore, Vinícius Oliveira Lord, Mariana Recamonde‐Mendoza, Thayne Woycinck Kowalski, Fernanda Sales Luiz Vianna · 2023 · Biochemical Genetics
  48. Organoids and microphysiological systems for pharmaceutical research of viral respiratory infections
    Sayaka Deguchi, Fuki Yokoi, Kazuo Takayama · 2024 · Drug Metabolism and Pharmacokinetics
  49. Antiandrogens as Therapies for COVID-19: A Systematic Review
    Massimiliano Cani, Samantha Epistolio, Giulia Dazio, Mikol Modesti, Giuseppe Salfi, Martino Pedrani, Luca Isella, Silke Gillessen, Ursula Maria Vogl, Luigi Tortola et al. · 2024 · Cancers
  50. Elevated temperature inhibits SARS-CoV-2 replication in respiratory epithelium independently of the induction of IFN-mediated innate immune defences
    Vanessa Herder, Kieran Dee, Joanna K. Wojtus, Daniel Max Goldfarb, Christoforos Rozario, Quan Gu, Ruth F. Jarrett, Ilaria Epifano, Andrew Stevenson, Steven McFarlane et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  51. Advancing lung organoids toward clinical applications: a global perspective on research focus and future directions
    Xiaoyun Peng, Shi-Yan Tan, Xi Fu, Jiawei He, Qiong Ma, Fengming You, Liting You, Yifeng Ren, Yifeng Ren, Chuan Zheng · 2025 · Frontiers in Medicine
  52. Organoid for Air Pollution Toxicity Assessment: Advances and Environmental Applicability
    Yin Jia, Di Wu, Chen Xiu, Zeming Ye, Qing X. Li · 2025 · Environment & Health
  53. Epigenetic liquid biopsies reveal endothelial turnover and erythropoiesis in asymptomatic COVID-19
    R. Ben-Ami, Netanel Loyfer, Eden Cohen, Gavriel Fialkoff, Israa Sharkia, Sheina Piyanzin, Naama R Bogot, Danit Kochan, G. Kalak, A. Jarjoui et al. · 2025 · Life Science Alliance
  54. Mechanisms of Surfactant Maturation in Development and Disease
    Abida Islam Pranty-Weßelmann, Sara Cuevas Ocaña, Jennifer A. Dickens · 2025 · Physiology
  55. Epithelial stem cells at the intersection of tissue regeneration and pulmonary fibrosis
    Manuela Platé, Yoshihiko Kobayashi, Rachel Clare Chambers, Purushothama Rao Tata · 2021 · European Respiratory Society eBooks
  56. SARS-CoV-2 variants from COVID-19 positive cases in the Free State province, South Africa from July 2020 to December 2021
    Peter N. Mwangi, Javan Okendo, Milton T. Mogotsi, Ayodeji Emmanuel Ogunbayo, Olusesan Adeyemi Adelabu, Hlengiwe Sondlane, Makgotso Golda Maotoana, Lutfiyya Mahomed, Molefi Daniel Morobadi, Sabeehah Vawda et al. · 2022 · Frontiers in Virology
  57. An engineered A549 cell line expressing CD13 and TMPRSS2 is permissive to clinical isolate of human coronavirus 229E
    Laurensius Kevin Lie, Aleksandra Synowiec, Jedrzej Mazur, Łukasz Rąbalski, Krzysztof Pyrć · 2023 · Virology
  58. Regenerative Capacity of Alveolar Type 2 Cells Is Proportionally Reduced Following Disease Progression in Idiopathic Pulmonary Fibrosis-Derived Organoid Cultures
    Hyeon Kyu Choi, Gaeul Bang, Ju Hye Shin, Mi Hwa Shin, Ala Woo, Song Yee Kim, Sang Hoon Lee, Eun Young Kim, Hyo Sup Shim, Young Joo Suh et al. · 2024 · Tuberculosis & respiratory diseases
  59. The Different Immune Responses by Age Are due to the Ability of the Fetal Immune System to Secrete Primal Immunoglobulins Responding to Unexperienced Antigens
    Jangho Lee, Kyoungshik Cho, Hyejin Kook, Suman Kang, Yunsung Lee, Jiwon Lee · 2021 · International Journal of Biological Sciences
  60. Airway models in a pandemic: Suitability of models in modeling SARS-CoV-2
    Andrew Teo, Caroline Lin Lin Chua, Louisa Chan · 2022 · PLoS Pathogens
  61. The interplay of cells, polymers, and vascularization in three-dimensional lung models and their applications in COVID-19 research and therapy
    Toka A. Ahmed, Bassant Eldaly, Shadwa Eldosuky, Hoda A. Elkhenany, Azza M. El-Derby, Muhamed F. Elshazly, Nagwa El‐Badri · 2023 · Stem Cell Research & Therapy
  62. Research progress of lung organoids in infectious respiratory diseases
    ­Jun Li­, Wendong Yang, Xiaoli Liu, Keda Yang, Jialin Zhou, Xiaochun Yang · 2025 · European Journal of Pharmacology
  63. Early fibrotic niches establish tumour-permissive microenvironments
    Erik C. Cardoso, Hyeyoung Lee, Frances J. England, Hyunjin Cho, Robin A. Lu, Sagar Varankar, Moo Suk Park, Natasha Rekhtman, Bon‐Kyoung Koo, Benjamin D. Simons et al. · 2026 · Nature
  64. Respiratory microphysiological system in respiratory research: recent advances and future prospects
    Jiaxiang Yin, Zirong Bi, Tiankai Dai, Xiaoyue Aelita Zhu, Tao Xu, Huisheng Liu · 2025 · Respiratory Research
  65. In vitro tools for orally inhaled drug products—state of the art for their application in pharmaceutical research and industry and regulatory challenges
    Julia Katharina Metz, Marius Hittinger, Claus‐Michael Lehr · 2021 · In vitro models
  66. Relative infectivity of the SARS-CoV-2 Omicron variant in human alveolar cells
    Taewoo Kim, Kyoung Il Min, Jeong‐Sun Yang, Jun Won Kim, Jun‐Hyung Cho, Yun Ho Kim, Jeong Seok Lee, Young Tae Kim, Kyung-Chang Kim, Jeong Yeon Kim et al. · 2022 · iScience
  67. Crosslink between SARS-CoV-2 replication and cystic fibrosis hallmarks
    Virginia Lotti, Anna Lagni, Erica Diani, Claudio Sorio, Davide Gibellini · 2023 · Frontiers in Microbiology
  68. Towards the development of a SARS-CoV-2 variant risk assessment tool: expert consultation on the assessment of scientific evidence on emerging variants
    Nathalie Worp, Lorenzo Subissi, Mark D. Perkins, Maria D. Van Kerkhove, Anurag Agrawal, Meera A Chand, Janko van Beek, Bas B. Oude Munnink, Marion Koopmans · 2023 · The Lancet Microbe
  69. Lung organoids: powerful tools for studying lung stem cells and diseases
    Hiroaki Katsura, Brigid L.M. Hogan · 2021 · European Respiratory Society eBooks
  70. 3D printing technologies forin vitrovaccine testing platforms and vaccine delivery systems against infectious diseases
    Ji Young Choi, Bhushan P. Mahadik, John P. Fisher · 2021 · Essays in Biochemistry
  71. Stem Cells as a Model of Study of SARS‐CoV‐2 and COVID‐19: A Systematic Review of the Literature
    María Verónica Cuevas-González, Álvaro García Pérez, Álvaro Edgar González-Aragón Pineda, León Francisco Espinosa-Cristóbal, Alejandro Donohué-Cornejo, Karla Lizette Tovar-Carrillo, Rosa Alicia Saucedo-Acuña, Juan Carlos Cuevas‐González · 2021 · BioMed Research International
  72. State-of-the-art analytical methods of viral infections in human lung organoids
    Morris Baumgardt, Maren Hülsemann, Anna Löwa, Diana Fatykhova, Karen Hoffmann, Mirjana Kessler, Maren Mieth, Katharina Hellwig, Doris Frey, Alina Katharina Langenhagen et al. · 2022 · PLoS ONE
  73. Modeling diverse genetic subtypes of lung adenocarcinoma with a next-generation alveolar type 2 organoid platform
    Santiago Naranjo, Christina M. Cabana, Lindsay M. LaFave, Peter M.K. Westcott, Rodrigo Romero, Arkopravo Ghosh, Laura Z. Liao, Jason M. Schenkel, Isabella S. Del Priore, Arjun J. Bhutkar et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  74. Bioprinted Four-Cell-Type Lung Model for Viral Infection Studies Under Air–Liquid Interface Conditions
    Johanna Berg, Julian Heinze, Daniela Niemeyer, Josefin Hellgren, Himjyot Jaiswal, Anna Löwa, Andreas Christian Hocke, Itedale Namro, Christian Drosten, Jens Kurreck et al. · 2025 · International Journal of Molecular Sciences
  75. Advancement of a Physiologically Relevant 3D Lung Model through One-Stage DLP Bioprinting for the Study of Lung Diseases
    Olatunji Ajiteru, Ok Joo Lee, Jin-Soo Kim, Ji Seung Lee, Hanna Lee, Kyu Young Choi, In‐Sun Hong, Hyung‐Joo Kwon, Soon Hee Kim, Chan Hum Park · 2025 · ACS Applied Materials & Interfaces
  76. Organoid Models: Revolutionizing Disease Modeling and Personalized Therapeutics
    Zhifeng Xue, Runze Yang, Yaling Liu, Han Luo · 2026 · Organoids
  77. Unveiling alternate pathways for SARS-CoV-2 infection via extracellular vesicle-mediated transfer of ACE2 and TMPRSS2
    Martha Rea-Moreno, Lu Tian, Tara N. Tavakol, Min-Chi Yang, Nicole Min Qian Pek, Shubham Gulati, Helena Bugacov, Cristina Cusmai, Gbalekan Dawodu, Remi V. Klotz et al. · 2026 · Nature Communications
  78. Bronchoalveolar lavage fluid (BALF): Clinical applications for present and future
    Jie Mei, Yuan-Shen Chen, Huixiang Tian, Lei‐Yun Wang, Jun Zeng, Luozixian Wang, Ding‐Chao Rong, Raymond C.B. Wong, Yang Gao, Chengxian Guo et al. · 2025 · The Innovation Medicine
  79. Polyphyllin I inhibits ovarian cancer growth by inducing G0/G1 phase arrest and inhibiting the c-Myc signaling pathway
    Qing Tang, Kun Huang, Mengjie Li, Ziqiao Zhao, Yuanle Deng, Yueqi Zuo, Ningyu Wang, Yongxia Zhu · 2025 · Medical Oncology
  80. Organotypic human lung bud microarrays identify BMP-dependent SARS-CoV-2 infection in lung cells
    Edwin A. Rosado-Olivieri, Brandon S. Razooky, Janic Le Pen, Riccardo De Santis, Douglas Barrows, Ziad Sabry, Hans-Heinrich Hoffmann, J. Park, Thomas S. Carroll, John Thomas Poirier et al. · 2023 · Stem Cell Reports
  81. Deciphering the triad of infection, immunity and pathology
    Frederik Graw · 2021 · eLife
  82. FXR inhibition reduces ACE2 expression, SARS-CoV-2 infection and may improve COVID-19 outcome
    Teresa Brevini, Mailis Maes, Gwilym James Webb, William Gelson, Sally Forrest, Petra Mlčochová, Scott Dillon, Sagar Varankar, Mahnaz Darvish-Damavandi, Victoria Mulcahy et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  83. Modelling the within-host spread of SARS-CoV-2 infection, and the subsequent immune response, using a hybrid, multiscale, individual-based model. Part I: Macrophages
    Christopher Rowlatt, Mark A. J. Chaplain, David J. Hughes, Stephen H. Gillespie, David Harold Dockrell, Ingólfur Johannessen, Ruth Bowness · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  84. Human Lung Alveolar Model with an Autologous Innate and Adaptive Immune Compartment
    Linda Steinacher, Bruno Gjeta, Marisa Pimentel Mendes, Floriana Cremasco, Irineja Cubela, Marina Bellavista, Laura Gaspa-Toneu, Luisa Lauer, Qianhui Yu, Ryo Okuda et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  85. Three-dimensional cell culture models in respiratory virus research: technological advances and current applications
    Zhen Hu, Yun-E Xu, J M Li, Yutong Wang, Hong Yan Song, Di-Shu Ao · 2025 · Journal of Materials Chemistry B
  86. Lung-on-a-Chip Models of the Lung Parenchyma
    Pauline Zamprogno, Jan Schulte, Dario Ferrari, Karin Farah Rechberger, Arunima Sengupta, Lisette van Os, Tobias Weber, Soheila Zeinali, Thomas Geiser, Olivier T. Guenat · 2023 · Advances in experimental medicine and biology
  87. Harnessing high-throughput OMICS in emerging zoonotic virus preparedness and response activities
    Kristi Loeb, Candice Lemaille, Christina Frederick, Hannah L. Wallace, Jason Kindrachuk · 2024 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  88. Applications of human lung organoids to human respiratory virus research: advances, limitations and future directions
    Qi Chen, Huaiqing Qi, Jun Guo · 2025 · Infection
  89. SARS-CoV-2 infection studies in lung organoids identify TSPAN8 as novel mediator
    Jeroen P. Roose, Lisiena Hysenaj, Samantha Little, Kayla R. Kulhanek, Oghenekevwe M. Gbenedio, Lauren Rodriguez, Alan S. Shen, Jean-Chrostophe Lone, Leonard C. Lupin-Jimenez, Luke R. Bonser et al. · 2021 · Research Square
  90. Modeling diverse genetic subtypes of lung adenocarcinoma with a next-generation alveolar type 2 organoid platform
    Santiago Naranjo, Christina M. Cabana, Lindsay M. LaFave, Peter M.K. Westcott, Rodrigo Romero, Arkopravo Ghosh, Laura Z. Liao, Jason M. Schenkel, Isabella S. Del Priore, Tyler Jacks · 2022 · Research Square
  91. Enhanced application potential of alveolar organoids through epithelial and niche cell interactions
    Min Jae Lim, Seung Joon Kim, Ayoung Jo, Sung Won Kim · 2025 · Scientific Reports
  92. Experimental Models to Investigate Viral and Cellular Dynamics in Respiratory Viral Co-Infections
    Ozge Yazici, C. Vanetti, Mario Clerici, M. Biasin · 2025 · Microorganisms
  93. Functionalized collagen-based biomaterials via self-assembly: implications for gastrointestinal health
    Ma Qin, Yuanmeng He, Yunxiang He, Yue Wu, Qinling Liu, Yulin Guan, Lie Yang, Junling Guo · 2025 · Collagen and Leather
  94. Recent Advancements in the Generation and Application of Therapeutic Cell Populations for Lung Epithelial Repair
    Muyang Zhou, Dana Brinson, Cindy Lei, Golnaz Karoubi · 2025 · Journal of Tissue Engineering and Regenerative Medicine
  95. Disease modeling and drug screening using human airway organoids: a systematic review
    Do Hyun Kim, Sung Won Kim · 2021 · Organoid
  96. SCARLET (Supplemental Citicoline Administration to Reduce Lung injury Efficacy Trial): study protocol for a single-site, double-blinded, placebo-controlled, and randomized Phase 1/2 trial of i.v. citicoline (CDP-choline) in hospitalized SARS CoV-2-infected patients with hypoxemic acute respiratory failure
    Sonal R. Pannu, Matthew C. Exline, Joseph S. Bednash, Joshua A. Englert, Philip Diaz, Amy Bartlett, Guy Nathaniel Brock, Qing Wu, Ian C. Davis, Elliott D. Crouser · 2024 · Trials
  97. SARS-CoV-2 Infection of Human Lung Air-Liquid Interface Cultures Reveals Basal Cells as Relevant Targets
    Morris Baumgardt, Benedikt Obermayer, Anita Balázs, Anna Löwa, Emanuel Wyler, Luiz Gustavo Teixeira Alves, Katharina Hellwig, Dieter Beule, Markus Landthaler, Marcel A. Müller et al. · 2025 · The Journal of Infectious Diseases
  98. Cigarette smoke preferentially induces full length ACE2 expression in differentiated primary human airway cultures but does not alter the efficiency of cellular SARS-CoV-2 infection
    Linsey Porter, Wenrui Guo, Thomas W. M. Crozier, Edward J. D. Greenwood, Brian M. Ortmann, Daniel Kottmann, James A. Nathan, Ravindra Mahadeva, Paul J. Lehner, Frank McCaughan · 2023 · Heliyon
  99. National Heart, Lung, and Blood Institute and Building Respiratory Epithelium and Tissue for Health (BREATH) Consortium Workshop Report: Moving Forward in Lung Regeneration
    Robert E. Hynds, William J. Zacharias, Marko Nikolić, Mélanie Königshoff, Oliver Eickelberg, Reinoud Gosens, Paolo De Coppi, Sam M. Janes, Edward E. Morrisey, Hans C. Clevers et al. · 2021 · American Journal of Respiratory Cell and Molecular Biology
  100. Impact of BNT162b first vaccination on the immune transcriptome of elderly patients infected with the B.1.351 SARS-CoV-2 variant
    Ludwig Knabl, Hye‐Kyung Lee, Manuel Wieser, Anna Mur, August Felix Zabernigg, Ludwig Knabl, Simon Rauch, Matthias Böck, Jana Schumacher, Norbert Kaiser et al. · 2021 · medRxiv